Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unique Identifiers Offer Little Attraction For Device Makers – FDA Report

This article was originally published in The Gray Sheet

Executive Summary

Despite holding the potential to make substantial improvements in healthcare, the development of a universal coding system for uniquely identifying every medical device is not in the best economic interest of device makers, according to a report posted on FDA's website June 1

You may also be interested in...



FDA Examines Unique Identifiers; Industry Pushes Voluntary System

FDA asks for comments on the potential for unique device identifier coding and offers details of its vision for such a system in a document published in the Aug. 11 Federal Register

FDA Examines Unique Identifiers; Industry Pushes Voluntary System

FDA asks for comments on the potential for unique device identifier coding and offers details of its vision for such a system in a document published in the Aug. 11 Federal Register

CDRH Expresses Renewed Interest In Unique Device Identifiers

CDRH Director Dan Schultz says the creation of a universal identifier system that could track the distribution of individual devices is feasible, in spite of industry concerns that such a system could be too costly

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel